tiprankstipranks
Trending News
More News >
DKS Co., Ltd. (JP:4461)
:4461
Japanese Market
Advertisement

DKS Co., Ltd. (4461) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4461

DKS Co., Ltd.

(4461)

Rating:69Neutral
Price Target:
¥5,720.00
▲(26.41%Upside)
DKS Co., Ltd. demonstrates strong financial performance with robust revenue growth and effective cash management, which significantly supports its stock score. Technical analysis indicates a strong upward trend, although overbought conditions could lead to volatility. Valuation metrics suggest the stock is fairly priced, but the dividend yield is relatively low. Overall, the company is well-positioned for future growth, though investors should be cautious of potential short-term price fluctuations.

DKS Co., Ltd. (4461) vs. iShares MSCI Japan ETF (EWJ)

DKS Co., Ltd. Business Overview & Revenue Model

Company DescriptionDKS Co., Ltd. (4461) is a Japanese company primarily engaged in the chemical industry. The company specializes in the production and sale of a wide range of chemical products, including surfactants, functional materials, and other chemical compounds. These products serve various sectors, including cosmetics, pharmaceuticals, agriculture, and industrial applications, highlighting the company's diverse involvement in multiple industries.
How the Company Makes MoneyDKS Co., Ltd. generates revenue through the manufacture and sale of its chemical products. The company's key revenue streams include sales of surfactants, which are used extensively in personal care and household cleaning products, and functional materials that cater to electronics and industrial sectors. Partnerships with companies in cosmetics, pharmaceuticals, and agriculture further bolster its earnings, as DKS supplies essential chemical components to these industries. The company's focus on research and development enables it to innovate and meet the evolving demands of its clients, driving sustained revenue growth.

DKS Co., Ltd. Financial Statement Overview

Summary
DKS Co., Ltd. exhibits strong financial health with notable revenue growth and improved profitability margins. The balance sheet is well-managed, with a solid equity base and manageable debt levels. Cash flow trends are positive, showing effective cash conversion and reinvestment strategies.
Income Statement
78
Positive
DKS Co., Ltd. has demonstrated strong revenue growth with a 16.08% increase in revenue from 2024 to 2025. The Gross Profit Margin improved to 24.89%, showing effective cost management. EBIT and EBITDA margins have also improved to 7.31% and 11.85% respectively, indicating enhanced operational efficiency. Net Profit Margin increased to 3.53%, a positive trend from previous years, enhancing overall profitability.
Balance Sheet
72
Positive
The Debt-to-Equity Ratio is 0.81, suggesting a stable leverage position. The company's Return on Equity improved to 6.67%, reflecting efficient use of equity to generate profits. The Equity Ratio stands at 39.88%, indicating a solid financial structure with significant equity backing. There is a consistent increase in total assets, further strengthening the balance sheet.
Cash Flow
75
Positive
Operating Cash Flow to Net Income Ratio is strong at 2.91, showing robust cash generation relative to net income. Free Cash Flow grew by 17.41% from 2024 to 2025, indicating better capital management. The Free Cash Flow to Net Income Ratio is 2.08, emphasizing the company's ability to convert earnings into cash.
BreakdownMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue73.25B63.12B65.08B62.67B59.14B
Gross Profit18.24B13.15B12.96B15.72B15.18B
EBITDA8.68B5.85B3.83B8.21B7.95B
Net Income2.58B1.17B-407.00M2.49B2.56B
Balance Sheet
Total Assets97.11B94.54B85.03B86.47B85.03B
Cash, Cash Equivalents and Short-Term Investments16.75B16.13B9.13B12.22B11.60B
Total Debt31.35B35.14B32.47B30.87B32.10B
Total Liabilities52.60B53.24B46.73B46.09B47.63B
Stockholders Equity38.73B36.75B34.35B36.77B34.65B
Cash Flow
Free Cash Flow5.39B4.59B-2.11B2.86B557.00M
Operating Cash Flow7.53B7.09B724.00M5.52B4.96B
Investing Cash Flow-2.14B-2.01B-2.88B-2.70B-3.80B
Financing Cash Flow-5.04B1.65B-1.03B-2.34B255.00M

DKS Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price4525.00
Price Trends
50DMA
3818.60
Positive
100DMA
3225.16
Positive
200DMA
3298.68
Positive
Market Momentum
MACD
214.72
Negative
RSI
79.44
Negative
STOCH
94.10
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4461, the sentiment is Positive. The current price of 4525 is above the 20-day moving average (MA) of 4162.25, above the 50-day MA of 3818.60, and above the 200-day MA of 3298.68, indicating a bullish trend. The MACD of 214.72 indicates Negative momentum. The RSI at 79.44 is Negative, neither overbought nor oversold. The STOCH value of 94.10 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4461.

DKS Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
¥43.37B18.42
3.43%13.35%36.31%
78
Outperform
¥35.36B3.77
3.94%0.79%104.86%
74
Outperform
¥25.30B7.75
4.41%9.75%28.00%
73
Outperform
¥34.69B11.75
2.72%-0.44%11.34%
72
Outperform
¥28.85B12.10
2.03%15.27%48.08%
69
Neutral
¥46.08B14.63
1.00%11.99%31.00%
62
Neutral
$10.39B9.841.51%2.86%2.35%-34.25%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4461
DKS Co., Ltd.
5,230.00
1,792.85
52.16%
JP:4094
Nihon Kagaku Sangyo Co., Ltd.
2,188.00
826.59
60.72%
JP:4112
Hodogaya Chemical Co., Ltd.
1,532.00
-891.06
-36.77%
JP:4462
Ishihara Chemical Company,Ltd.
1,970.00
-442.86
-18.35%
JP:4464
Soft99 Corporation
1,589.00
71.12
4.69%
JP:4611
Dai Nippon Toryo Company, Limited
1,243.00
91.78
7.97%

DKS Co., Ltd. Corporate Events

DKS Co., Ltd. Revises Financial Forecasts Upward Amid Strong Product Growth
Jul 29, 2025

DKS Co., Ltd. has revised its financial forecasts for the six months ending September 30, 2025, and the fiscal year ending March 31, 2026, reflecting a significant increase in expected profits. This upward revision is driven by strong growth in high-value-added products, despite uncertainties like U.S. tariff measures and exchange rate fluctuations. The company anticipates that profits for both the six-month period and the fiscal year will exceed initial estimates, indicating a positive impact on its operations and market positioning.

DKS Co., Ltd. Reports Strong Q1 Financial Performance and Revises Earnings Forecast
Jul 29, 2025

DKS Co., Ltd. reported a significant increase in its financial performance for the three months ended June 30, 2025, with net sales rising by 8.6% and operating income increasing by 62.8% year-on-year. The company revised its earnings forecast for the fiscal year ending March 31, 2026, indicating positive expectations for future growth, which may enhance its market positioning and stakeholder confidence.

DKS Co., Ltd. Completes Treasury Stock Disposition
Jul 15, 2025

DKS Co., Ltd. has announced the completion of payment procedures for the disposition of treasury stock under its restricted stock compensation plan. This move, resolved at the Board of Directors meeting on June 25, 2025, involves the disposal of 5,901 shares of common stock at a price of 3,810 yen per share, totaling 22,482,810 yen. The allotment is aimed at directors and audit & supervisory board members, reflecting the company’s commitment to aligning executive interests with shareholder value.

DKS Co., Ltd. Announces Treasury Stock Disposal Under Compensation Plan
Jun 25, 2025

DKS Co., Ltd. has announced the disposal of 5,901 shares of its treasury stock under a Restricted Stock Compensation Plan, as resolved by its Board of Directors. This move is part of a broader strategy to align the interests of its directors and supervisory board members with those of its shareholders, facilitating the achievement of targets set in its medium-term management plan, SMART 2030.

DKS Co., Ltd. Expands Business Focus to Include Agriculture
Jun 16, 2025

DKS Co., Ltd. has announced a proposal to amend its Articles of Incorporation to include agricultural products as part of its business objectives. This strategic move aims to strengthen its Life & Wellness business and promote new business development to address social issues, potentially enhancing its market position and offering new opportunities for stakeholders.

DKS Co., Ltd. Reports Strong Financial Growth for Fiscal Year 2025
May 14, 2025

DKS Co., Ltd. reported a significant increase in its financial performance for the fiscal year ended March 31, 2025, with net sales rising by 16.1% and operating income surging by 157.6%. This growth reflects the company’s strong market positioning and effective operational strategies, potentially benefiting stakeholders through increased dividends and a positive outlook for the upcoming fiscal year.

DKS Co., Ltd. Reports Extraordinary Loss Due to Impairment
May 14, 2025

DKS Co., Ltd. announced an extraordinary loss due to an impairment loss of ¥365 million on fixed assets held by its subsidiary, IKEDA YAKUSOU Co., Ltd., for the fourth quarter of the fiscal year ending March 31, 2025. This financial adjustment reflects the company’s adherence to the Accounting Standard for Impairment of Fixed Assets, impacting its financial results for the period.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 30, 2025